Literature DB >> 12522650

Adrenomedullin and nitrite levels in children with dilated cardiomyopathy.

M Kilinç1, A Balat, M Cekmen, M Yürekli, K Yilmaz, S Sahinöz.   

Abstract

Dilated cardiomyopathy (DCM) is an important cause of chronic congestive cardiac failure in children. In patients with idiopathic DCM, endothelium vasomotor function is disturbed. There are many studies on the roles of nitric oxide (NO) and adrenomedullin (AM) in adult patients with DCM. However, to our knowledge, no studies have investigated the level of AM and NO in children with idiopathic DCM. We determined plasma and urinary AM and total nitrite concentrations in children with idiopathic DCM and investigated the correlation between these and other clinical and laboratory findings. Eleven patients with DCM, ranging in age from 5 month to 14 years, were compared to 10 healthy age- and sex-matched controls. Plasma (pmol/ml) and urinary (pmol/mg creatinine) AM levels were significantly lower than in the healthy controls (19.55 +/- 2.36 vs 51.61 +/- 7.22 and 28.29 +/- 20.66 vs 68.87 +/- 40.23, respectively; p <0.001). Plasma and urinary AM levels were negatively correlated with ejection fraction (EF) and fractional shortening (FS). The plasma (Mmol/L) and urinary nitrite levels (Mmol/mg creatinine) were not different between patients and controls [50.90 +/- 17.50 VS 53.40 +/- 26.05 (P > 0.05) and 1.98 +/- 1.24 vs 2.75 +/- 1.68 (p > 0.05), respectively]. In our study, the first to analyze AM and nitrite levels in children with DCM, plasma and urinary AM levels were found to be decreased. A possible explanation for this reduction could be depletion of the viable myocyte population. However, this hypothesis must be clarified by further studies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12522650     DOI: 10.1007/s00246-002-0352-8

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  28 in total

1.  Expression of inducible nitric oxide synthase in human heart failure.

Authors:  G A Haywood; P S Tsao; H E von der Leyen; M J Mann; P J Keeling; P T Trindade; N P Lewis; C D Byrne; P R Rickenbacher; N H Bishopric; J P Cooke; W J McKenna; M B Fowler
Journal:  Circulation       Date:  1996-03-15       Impact factor: 29.690

2.  Elevated circulating levels of tumor necrosis factor in severe chronic heart failure.

Authors:  B Levine; J Kalman; L Mayer; H M Fillit; M Packer
Journal:  N Engl J Med       Date:  1990-07-26       Impact factor: 91.245

3.  Gene expression of adrenomedullin in failing myocardium: comparison to atrial natriuretic peptide.

Authors:  Anselm T Bäumer; Christina Schumann; Bodo Cremers; Gabi Itter; Wolfgang Linz; Friedrich Jockenhövel; Michael Böhm
Journal:  J Appl Physiol (1985)       Date:  2002-03

4.  Plasma adrenomedullin, a new independent predictor of prognosis in patients with chronic heart failure.

Authors:  F Pousset; F Masson; O Chavirovskaia; R Isnard; A Carayon; J L Golmard; P Lechat; D Thomas; M Komajda
Journal:  Eur Heart J       Date:  2000-06       Impact factor: 29.983

Review 5.  Adrenomedullin and the control of fluid and electrolyte homeostasis.

Authors:  W K Samson
Journal:  Annu Rev Physiol       Date:  1999       Impact factor: 19.318

6.  Loss of nitric oxide production in the coronary circulation after the development of dilated cardiomyopathy: a specific defect in the neural regulation of coronary blood flow.

Authors:  G Zhao; W Shen; X Zhang; C J Smith; T H Hintze
Journal:  Clin Exp Pharmacol Physiol       Date:  1996-08       Impact factor: 2.557

7.  Differential hormonal profiles of adrenomedullin and proadrenomedullin N-terminal 20 peptide in patients with heart failure and effect of treatment on their plasma levels.

Authors:  T Etoh; J Kato; M Takenaga; T Imamura; K Kitamura; Y Koiwaya; T Eto
Journal:  Clin Cardiol       Date:  1999-02       Impact factor: 2.882

8.  Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure.

Authors:  T Ishimitsu; T Nishikimi; Y Saito; K Kitamura; T Eto; K Kangawa; H Matsuo; T Omae; H Matsuoka
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

9.  Role of endothelium-derived nitric oxide in the modulation of canine myocardial mitochondrial respiration in vitro. Implications for the development of heart failure.

Authors:  Y W Xie; W Shen; G Zhao; X Xu; M S Wolin; T H Hintze
Journal:  Circ Res       Date:  1996-09       Impact factor: 17.367

10.  The L-arginine:nitric oxide pathway is the major source of plasma nitrite in fasted humans.

Authors:  P Rhodes; A M Leone; P L Francis; A D Struthers; S Moncada; P ] Rhodes PM [corrected to Rhodes
Journal:  Biochem Biophys Res Commun       Date:  1995-04-17       Impact factor: 3.575

View more
  1 in total

Review 1.  A Review of Adrenomedullin in Pediatric Patients: A Useful Biomarker.

Authors:  Anna Solé-Ribalta; Sara Bobillo-Pérez; Iolanda Jordan-García
Journal:  Children (Basel)       Date:  2022-08-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.